Source:http://linkedlifedata.com/resource/pubmed/id/10074901
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1999-5-21
|
| pubmed:abstractText |
The early incidence of p53 mutation in astrocytomas suggests that it plays an important role in astrocyte transformation. Astrocytes isolated from homozygous p53 knockout mice grow rapidly, lack contact inhibition, and are immortal. Here we tested whether the loss of p53 is sufficient for progression to tumorigenicity of astrocytes. We grew primary astrocytes under three conditions for over 120 population doublings and assessed their antigenic phenotype, chromosome number, and expression of glioma-associated genes as well as their ability to form colonies in soft agarose and tumors s.c. and intracranially in nude mice. Under two conditions (10% FCS and 0.5% FCS plus 20 ng/ml EGF), cells acquired the ability to form colonies in soft agarose and tumors in nude mice, and this was accompanied by the expression of genes, including epidermal growth factor receptor, platelet-derived growth factor receptor alpha and beta, protein kinase Cdelta, and vascular endothelial growth factor, which are known to be aberrantly regulated in human astrocytomas. Under the third condition (0.5% FCS plus 10 ng/ml basic fibroblast growth factor), astrocytes gained the ability to form colonies in soft agarose and had abnormal chromosome numbers similar to cells in the first two conditions but did not form tumors in nude mice or overexpress glioma-associated genes. These data provide experimental evidence for the idea that the malignant progression initiated by the loss of p53 may be subject to modulation by extracellular environmental influences.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Platelet-Derived Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1044-9523
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
73-86
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:10074901-Aneuploidy,
pubmed-meshheading:10074901-Animals,
pubmed-meshheading:10074901-Astrocytes,
pubmed-meshheading:10074901-Blotting, Northern,
pubmed-meshheading:10074901-Brain,
pubmed-meshheading:10074901-Brain Neoplasms,
pubmed-meshheading:10074901-Carcinogenicity Tests,
pubmed-meshheading:10074901-Cell Culture Techniques,
pubmed-meshheading:10074901-Cell Division,
pubmed-meshheading:10074901-Cell Transformation, Neoplastic,
pubmed-meshheading:10074901-Cells, Cultured,
pubmed-meshheading:10074901-Culture Media,
pubmed-meshheading:10074901-Epidermal Growth Factor,
pubmed-meshheading:10074901-Fibroblast Growth Factor 2,
pubmed-meshheading:10074901-Glioma,
pubmed-meshheading:10074901-Humans,
pubmed-meshheading:10074901-Mice,
pubmed-meshheading:10074901-Mice, Nude,
pubmed-meshheading:10074901-Receptor, Epidermal Growth Factor,
pubmed-meshheading:10074901-Receptors, Platelet-Derived Growth Factor,
pubmed-meshheading:10074901-Time Factors,
pubmed-meshheading:10074901-Tumor Stem Cell Assay,
pubmed-meshheading:10074901-Tumor Suppressor Protein p53
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
|
| pubmed:affiliation |
Ludwig Institute for Cancer Research, La Jolla, California, USA. obogler@hsc.vcu.edu
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|